Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
AstraZeneca
AstraZeneca
BeOne Medicines
AstraZeneca
Teclison Ltd.
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
Bayer
Zymeworks BC Inc.
Bristol-Myers Squibb
TaiRx, Inc.
7 Hills Pharma, LLC
Nammi Therapeutics Inc
RayzeBio, Inc.
TaiRx, Inc.
Beijing Biotech
Parabilis Medicines, Inc.
Compass Therapeutics
Pfizer
Tvardi Therapeutics, Incorporated
AstraZeneca
Genentech, Inc.
Replimune Inc.
HistoSonics, Inc.
Alnylam Pharmaceuticals
Boston Scientific Corporation
Aptamer Sciences, Inc.
Hoffmann-La Roche
3D Medicines
Guangzhou FineImmune Biotechnology Co., LTD.
Wuhan Ammunition Life-tech Co., Ltd
Akeso
Shanghai Henlius Biotech
Exelixis
Akeso
ViroMissile, Inc.
Seagen Inc.
SEED Therapeutics, Inc.
Daiichi Sankyo
DualityBio Inc.
MacroGenics
SAPU NANO (US) LLC
Jiangsu Simcere Pharmaceutical Co., Ltd.
Guerbet
Wondercel Biotech (ShenZhen)
inTumo Therapeutics, Inc.
Replimune Inc.
AstraZeneca
Abbisko Therapeutics Co, Ltd
Newish Technology (Beijing) Co., Ltd.
Shanghai AbelZeta Ltd.
Dysplasia Diagnostics Limited